- Home
- ISPC
ISPC
iSpecimen Inc.
as 03-28-2025 4:00pm EST
| Founded: | 2009 | Country: | United States |
| Employees: | N/A | City: | WOBURN |
| Market Cap: | N/A | IPO Year: | 2021 |
| Target Price: | N/A | AVG Volume (30 days): | 59.9K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -17.63 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.09 - $11.80 | Next Earning Date: | 05-06-2025 |
| Revenue: | $10,390,702 | Revenue Growth: | 0.74% |
| Revenue Growth (this year): | 13.82% | Revenue Growth (next year): | 11.76% |
Latest iSpecimen Inc. News
ISPC Breaking Stock News: Dive into ISPC Ticker-Specific Updates for Smart Investing
Newsfile
2 months ago
iSpecimen Secures Suppliers for COVID-style hMPV Outbreak
Newsfile
3 months ago
iSpecimen Will Serve as a Preferred Provider of Cancer Biospecimens
Newsfile
4 months ago
iSpecimen Reports Positive Results on Next Day Quote Program for Researchers and Providers
Newsfile
4 months ago
iSpecimen Appoints Robert Lim as CEO and Director
Newsfile
5 months ago
iSpecimen Named Top Competitor in $4.4 Billion USD Market
GlobeNewswire
5 months ago
iSpecimen Releases Cancer Biospecimen Offering; Orders Anticipated of Over $9,500,000 Annually
GlobeNewswire
5 months ago
iSpecimen Reports Third Quarter 2024 Results
GlobeNewswire
5 months ago
iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants
Compare ISPC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ISPC iSpecimen Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.